These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23701013)

  • 1. Development and clinical gains of nurse-led medication monitoring profiles.
    Gabe ME; Jordan SE
    J Nurs Manag; 2014 Apr; 22(3):331-49. PubMed ID: 23701013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile.
    Gabe ME; Murphy F; Davies GA; Russell IT; Jordan S
    PLoS One; 2014; 9(5):e96682. PubMed ID: 24798210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring adverse drug reactions: scales, profiles, and checklists.
    Jordan S; Knight J; Pointon D
    Int Nurs Rev; 2004 Dec; 51(4):208-21. PubMed ID: 15530161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse-led medicines' monitoring in care homes, implementing the Adverse Drug Reaction (ADRe) Profile improvement initiative for mental health medicines: An observational and interview study.
    Jordan S; Banner T; Gabe-Walters M; Mikhail JM; Panes G; Round J; Snelgrove S; Storey M; Hughes D;
    PLoS One; 2019; 14(9):e0220885. PubMed ID: 31509537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurse-led medicines monitoring: a study examining the effects of the West Wales Adverse Drug Reaction Profile.
    Jones R; Moyle C; Jordan S
    Nurs Stand; 2016 Nov; 31(14):42-53. PubMed ID: 27902153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication monitoring for people with dementia in care homes: the feasibility and clinical impact of nurse-led monitoring.
    Jordan S; Gabe M; Newson L; Snelgrove S; Panes G; Picek A; Russell IT; Dennis M
    ScientificWorldJournal; 2014; 2014():843621. PubMed ID: 24707218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped Wedge Cluster Randomised Trial.
    Jordan S; Gabe-Walters ME; Watkins A; Humphreys I; Newson L; Snelgrove S; Dennis MS
    PLoS One; 2015; 10(10):e0140203. PubMed ID: 26461064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From a Suspect Victim to the Holmes: The Unexpected Value of a Home-Made Mobile Chemotherapy Medication Administration System.
    Kuo MC; Chang P
    Stud Health Technol Inform; 2016; 225():840-1. PubMed ID: 27332369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
    Kane-Gill SL; Kirisci L; Pathak DS
    Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing adverse drug reactions: an orphan task.
    Jordan S
    J Adv Nurs; 2002 Jun; 38(5):437-48. PubMed ID: 12028277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a new instrument for detecting preventable adverse drug reactions.
    Benkirane R; Soulaymani-Bencheikh R; Khattabi A; Benabdallah G; Alj L; Sefiani H; Hedna K; Ouammi L; Olsson S; Pal SN
    Drug Saf; 2015 Apr; 38(4):383-93. PubMed ID: 25537235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving mental health service users' physical health through medication monitoring: a literature review.
    Nash M
    J Nurs Manag; 2011 Apr; 19(3):360-5. PubMed ID: 21507107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for evaluating adverse drug event preventability in emergency department patients.
    Woo SA; Cragg A; Wickham ME; Peddie D; Balka E; Scheuermeyer F; Villanyi D; Hohl CM
    BMC Med Res Methodol; 2018 Dec; 18(1):160. PubMed ID: 30514232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted method for standardized assessment of adverse drug events in surgical patients.
    de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
    J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nurses must report adverse drug reactions.
    Griffith R
    Br J Nurs; 2013 Apr 25-May 8; 22(8):484-5. PubMed ID: 23905231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacovigiance: The spontaneous reporting system in Switzerland].
    Schäublin M
    Ther Umsch; 2015 Dec; 72(11-12):743-8. PubMed ID: 26654819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions: managing the risk.
    Jordan S; Jones R; Sargeant MP
    J Nurs Manag; 2009 Mar; 17(2):175-84. PubMed ID: 19416420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.